Hölscher C - Search Results

1

The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD.

Li C, Liu W, Li X, Zhang Z, Qi H, Liu S, Yan N, Xing Y, Hölscher C, Wang Z. Li C, et al. Among authors: holscher c. Brain Behav. 2020 Mar;10(3):e01505. doi: 10.1002/brb3.1505. Epub 2020 Jan 20. Brain Behav. 2020. PMID: 31960630 Free PMC article.

2

Neuroprotective effects of geniposide on Alzheimer's disease pathology.

Liu W, Li G, Hölscher C, Li L. Liu W, et al. Among authors: holscher c. Rev Neurosci. 2015;26(4):371-83. doi: 10.1515/revneuro-2015-0005. Rev Neurosci. 2015. PMID: 25879319 Free article. Review.

3

Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Liu W, Jalewa J, Sharma M, Li G, Li L, Hölscher C. Liu W, et al. Among authors: holscher c. Neuroscience. 2015 Sep 10;303:42-50. doi: 10.1016/j.neuroscience.2015.06.054. Epub 2015 Jul 2. Neuroscience. 2015. PMID: 26141845

4

Neuroprotective effects of an oxyntomodulin analogue in the MPTP mouse model of Parkinson's disease.

Liu W, Li Y, Jalewa J, Saunders-Wood T, Li L, Hölscher C. Liu W, et al. Among authors: holscher c. Eur J Pharmacol. 2015 Oct 15;765:284-90. doi: 10.1016/j.ejphar.2015.08.038. Epub 2015 Aug 21. Eur J Pharmacol. 2015. PMID: 26302060

5

A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF.

Ji C, Xue GF, Lijun C, Feng P, Li D, Li L, Li G, Hölscher C. Ji C, et al. Among authors: holscher c. Brain Res. 2016 Mar 1;1634:1-11. doi: 10.1016/j.brainres.2015.09.035. Epub 2015 Oct 11. Brain Res. 2016. PMID: 26453833 Free article.

6

Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model.

Li Y, Liu W, Li L, Hölscher C. Li Y, et al. Among authors: holscher c. Neuropharmacology. 2016 Feb;101:255-63. doi: 10.1016/j.neuropharm.2015.10.002. Epub 2015 Nov 10. Neuropharmacology. 2016. PMID: 26453962 Free article.

7

D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation.

Li Y, Liu W, Li L, Hölscher C. Li Y, et al. Among authors: holscher c. Eur J Pharmacol. 2017 Feb 15;797:162-172. doi: 10.1016/j.ejphar.2016.11.050. Epub 2016 Nov 29. Eur J Pharmacol. 2017. PMID: 27913104 Free article.

8

A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model.

Shi L, Zhang Z, Li L, Hölscher C. Shi L, et al. Among authors: holscher c. Behav Brain Res. 2017 Jun 1;327:65-74. doi: 10.1016/j.bbr.2017.03.032. Epub 2017 Mar 23. Behav Brain Res. 2017. PMID: 28342971 Free article.

9

Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease.

Tai J, Liu W, Li Y, Li L, Hölscher C. Tai J, et al. Among authors: holscher c. Brain Res. 2018 Jan 1;1678:64-74. doi: 10.1016/j.brainres.2017.10.012. Epub 2017 Oct 16. Brain Res. 2018. PMID: 29050859 Free article.

10

A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease.

Li T, Jiao JJ, Hölscher C, Wu MN, Zhang J, Tong JQ, Dong XF, Qu XS, Cao Y, Cai HY, Su Q, Qi JS. Li T, et al. Among authors: holscher c. Hippocampus. 2018 May;28(5):358-372. doi: 10.1002/hipo.22837. Epub 2018 Mar 5. Hippocampus. 2018. PMID: 29473979

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

432 results

Search Page

Filters